The global Leukapheresis Market size is $20.95m in 2019 and is estimated to grow at a CAGR of 7.36% during the forecast period 2020–2025. The Leukapheresis market is projected to reach $32.01m by 2025. Leukapheresis is a procedure in which the white blood cells are separated from the blood sample. It is done to reduce the peripheral WBC counts in patients having hematological malignancies. The main application of Leukapheresis procedure is in the treatment of chronic leukemia. It is also used to reduce or alleviate symptoms of hyperleukocytosis and leukostasis, before chemotherapy, and other medical applications.
Leukapheresis market is growing at a CAGR of 7.36% during the forecast period 2020–2025.
As per The Leukemia & Lymphoma Society (LLS), in 2019, about 61,780 people are expected to be diagnosed with Leukemia. Leukapheresis is a treatment type for leukemia to reduce the count of WBCs. It is also used for other inflammatory diseases such as ulcerative colitis or rheumatoid arthritis.
North America dominates the market with major share. Leukapheresis disposable segment holds major share by revenue by type.
Download Sample Report @ https://www.industryarc.com/pdfdownload.php?id=505631
Type – Segment Analysis
In 2019, the Leukapheresis disposable segment is said to dominate the market by revenue. This is owing to its increasing use for cell therapy research applications. They also have regular requirement as compared to leukapheresis devices. These dispocables are also purchased in bulk to meet constant requirements, thus are contributing to the dominance of this segment revenue.
Application – Segment Analysis
The research segment is said to dominate the Leukapheresis market by application. Growing research in cancer treatments and cell therapy are said to contribute to the growth of this segment. This segment is said to be the fastest growing during the forecast period with a CAGR of 6.3%.
End User – Segment Analysis
The blood component provider and blood center end use industry is likely to dominate the market during the base year and is anticipated to do so in the coming years. This is due to the increasing number of blood donations being done as well as the rising demand for Leukopaks in conditions such as cancer.
Geography – Segment Analysis
In 2019, the Asia Pacific region occupied 32% of the global Leukapheresis Market share in terms of revenue. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.
Drivers – Leukapheresis Market
Growing incidence of diseases such as leukemia
There are an estimated 399,967 people living with or in remission from leukemia in the U.S. as per The Leukemia & Lymphoma Society. The high incidence of leukemia globally is said to drive the Leukapheresis market.
Rising number of blood donations and surging demand for Leukopaks
As per the WHO statistics, 117.4 million blood donations are collected globally. The rising demand for blood transfusions in patients with leukemia, lymphoma, and other blood disorders is said to contribute to the leukapheresis market growth. Blood donations have a short shelf life so regular supply of blood is required. Leukopaks are blood components procured from blood using leukapheresis. These blood components are required by patients who require such enriched blood cells. This demand for specific blood components will also contribute this market growth.
Challenges – Leukapheresis Market
High cost in Leukapheresis procedures
The cost associated with conducting leukapheresis procedure is very high. The machines used in apheresis are generally very expensive and this increases the cost of this procedure as well. Along with this, a lack of skilled professionals trained in this procedure further increases the expense of this procedure and hence said to restraint the market growth.
Leukapheresis industry outlook
Product Launches, Partnerships, and Business Expansions are the key strategies of the players in the Leukapheresis Industry. Leukapheresis top 10 companies include Allcells LLC, Asahi Kasei Medical Co , Ltd, Bioivt, Caltag Medsystems Limited, Fresenius Se & Co. Kgaa, Haemonetics Corporation, Hemacare Corporation, Key Biologics, Llc, Macopharma Sa, Ppa Research Group, Inc.
Leukapheresis Market Research Scope:
The base year of the study is 2019, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Leukapheresis market. The assessment includes the forecast, an overview of the competitive structure, the Leukapheresis market share of the competitors, as well as the Leukapheresis market size market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This Leukapheresis market report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include Leukapheresis type, drug type, route of administration, and geographic analysis.
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to firstname.lastname@example.org to discuss more about our consulting services.